5 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
ASCVD or ASCVD risk ... in HFrEF on GDMT ... outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... , heart failure; ... HFpEF, heart failure ... ejection fraction; HFrEF ... , heart failure
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... patients with HFrEF ... /ambcarerx #CHF ... #HFrEF #Pharmacology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
in Heart Failure ... showed reduced risk ... #deficiency #CHF ... #HFrEF #heartfailure ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
disease b) CHF ... > 1% risk of CV ... the type of and indication ... CARP, DECREASE V trials ... medical and surgical management